50+ Hotel Management Companies to Know in 2022

What hoteliers need to know before putting their properties in the hands of a professional manager

In the two years since the start of the global COVID-19 pandemic, the U.S. hotel industry has made significant progress toward recovery. U.S. hotels recaptured 83 percent of pre-pandemic RevPAR levels in 2021, and are expected to surpass the pre-pandemic comparable in 2023 on a nominal basis, according to STR and Tourism Economics’ latest forecast released earlier this year. Occupancy will likely exceed 2019 levels next year as well. Amid this resurgence in demand and revenues, hoteliers are looking to strategically position their assets and align themselves with the right partners to make the most of the opportunities ahead. This year, LODGING takes a look at more than 50 management companies that are working to help hotels recover and thrive in 2022 and beyond.

Editor’s note: The following list is in alphabetical order. All numbers are for the 2021 calendar year, U.S. only. 

Back
Next

Remington Hotels

Lakeway Resort & Spa

Remington Hotels is a growing hotel management company providing service and expertise in property management. Founded in 1968, the hospitality group has grown into a service provider that manages 86 hotels in 26 states across 17 brands, including 12 independent and boutique properties. At Remington, people are the source of its competitive advantage and deliver results to its owners and investors.

Editor’s note: In April 2022, Remington Hotels announced its acquisition of Chesapeake Hospitality, expanding its portfolio to 121 managed properties under contract in 28 states and Washington, D.C.  

Total Rooms Managed 17,315
Total Properties Managed 86
Third-Party Rooms Managed 17,315
Third-Party Properties Managed 86
Total Gross Revenue $642,720,400
Contact Jarrad Evans, info@remingtonhotels.com
Back
Next
Previous articleHyatt Centric Santa Clara Silicon Valley Opens
Next articleKimpton Hotels & Restaurants to Open UVA Property in 2023

1 COMMENT

Comments are closed.